High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.
Nos
C
C
Comabella
M
M
Tintoré
M
M
Rio
J
J
Codina
A
A
Montalban
X
X
Rovira
A
A
D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D001812:Blood-Brain Barrier / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage* / Q000494:pharmacology* / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D012008:Recurrence
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone